Altamira Therapeutics Market Cap

Altamira Therapeutics has a market cap or net worth of $371.79 thousand as of December 5, 2025. Its market cap has decreased by -82.62% in one year.

Market Cap

371.79K

Enterprise Value

1.16M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.07

Market Cap Chart

Since August 8, 2014, Altamira Therapeutics's market cap has decreased from 171.70M to 371.79K, a decrease of -99.78%. That is a compound annual growth rate of -41.81%.

Market Cap History

Date	Market Cap	% Change
Dec 4, 2025	371.79K	-1.08%
Dec 31, 2024	375.87K	-72.84%
Dec 29, 2023	1.38M	-75.59%
Dec 30, 2022	5.67M	-78.93%
Dec 31, 2021	26.91M	-10.02%
Dec 31, 2020	29.91M	459.11%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Veradigm	815.80M
Elite Pharmaceuticals	561.91M
Glass House Brands	513.14M
CytoDyn	403.93M
American Oncology Network	367.13M
Northwest Biotherapeutics	363.73M
Silence Therapeutics	328.75M
Nika Pharmaceuticals	259.91M

Market Cap Rankings